SCHEMBL1996284

SCHEMBL1996284

CN(C)CCN1CCC(n2cc(C3=C(c4c[nH]c5sccc45)C(=O)NC3=O)c3ccccc32)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 15/20 0.58
PRKCB P05771 14/20 0.58
PRKCE Q02156 14/20 0.58
PRKCG P05129 13/20 0.58
PRKCH P24723 13/20 0.58
PRKCD Q05655 13/20 0.58
CAMK2D Q13557 13/20 0.58
CAMK2B Q13554 9/20 0.58
CAMK2G Q13555 9/20 0.58
CAMK2A Q9UQM7 9/20 0.58
PRKCZ Q05513 8/20 0.58
SRC P12931 3/20 0.58
PRKACA P17612 7/20 0.51
PRKACB P22694 6/20 0.51
PRKCQ Q04759 5/20 0.51
PIM1 P11309 5/20 0.51
GSK3B P49841 4/20 0.51
RPS6KA1 Q15418 3/20 0.51
CLK2 P49760 3/20 0.51
GSK3A P49840 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1990883 0.90 CAMK2D (0.59) PRKCAPRKCBPRKCEPRKCGPRKCH
SCHEMBL1993731 0.89 CAMK2D (0.58) PRKCAPRKCBPRKCEPRKCGPRKCH
SCHEMBL1989734 0.88 PRKCB (0.59) PRKCAPRKCBPRKCEPRKCGPRKCH
SCHEMBL1989564 0.85 PRKCB (0.56) PRKCAPRKCBPRKCEPRKCGPRKCH
SCHEMBL1993777 0.85 CAMK2D (0.55) PRKCAPRKCBPRKCEPRKCGPRKCH
SCHEMBL1992365 0.85 CAMK2D (0.55) PRKCAPRKCBPRKCEPRKCGPRKCH
SCHEMBL1999066 0.85 PRKCG (0.43) PRKCAPRKCBPRKCEPRKCGPRKCH
SCHEMBL1991953 0.84 PRKCB (0.54) PRKCAPRKCBPRKCEPRKCGPRKCH
SCHEMBL1994400 0.82 PRKACA (0.65) PRKCAPRKCBPRKCEPRKCGPRKCH
SCHEMBL1991052 0.80 PRKCB (0.58) PRKCAPRKCBPRKCEPRKCGPRKCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011079105-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-30 WO disclosed
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO PRKCA 3438/4885PRKCB 3335/4885PRKCE 3431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.